StockData

Edap Tms vs Myomo

FOCL and MYO side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How FOCL and MYO compare

Myomo scores higher on the StockData Score (7 against 0 for Edap Tms), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricFOCLMYO
Size and price
Market cap–$36.4M
Share price$2.84$0.919
Change, 1 year35.2%12.6%
Change, 5 years−48.8%−89.2%
Beta (5Y)1.323.01
Employees289184
StockData Score
Total score07 (better)
Valuation score02 (better)
Growth score02 (better)
Performance score01 (better)
Health score02 (better)
Dividend score00
Valuation
P/S–0.8×
P/B–6.2×
FCF yield–−22.9%
Fair value–$1.31
Margin of safety–29.9%
Growth
Revenue growth (TTM)–6.1%
Revenue growth, 5Y average–40.1%
Profitability
Gross margin–68.4%
Operating margin–−27.1%
Net margin–−33.5%
FCF margin–−19.2%
Return on equity–−124%
Financial health
Debt / equity–0.08
Current ratio–2.31
Altman Z-score–−3.64
Piotroski F-score–3
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions41.5%30.8%
Held by insiders10.1%16.3%
Insider net buying, 12 months$593K (better)$203K
Short interest, % of float–3.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.